The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- Topics, Trends & Updates (11/12/20)
- Guidance: Strategies for STI Screening and Treatment During COVID-19 (11/5/2020)
- New Guideline: Substance Use Screening and Risk Assessment in Adults (10/21/20)
- Diagnosis and Management of HIV-2 in Adults Updated (10/5/20)
- Updated PEP Guideline Recommendations for Managing a Potential HCV Exposure (10/2/20)
- New Guidance: Screening, Diagnosis, and Treatment of Mycoplasma genitalium (9/28/20)
- Medscape Commentary: Growing Old With HIV: Beyond Just Surviving (9/17/20)
- Guidance: Rapid ART Initiation During COVID-19 (8/26/20)
- NYC DOHMH: Dear Colleague COVID-19 Updates, Preventing household transmission of SARS-CoV-2 (11/30/20)
- NYSDOH: Find a COVID-19 Test Site Near You (10/14/20)
- COVID Alert NY app now available (10/14/20)
- FDA MedWatch: Certain COVID-19 Serology/Antibody Tests Should Not Be Used - Letter to Clinical Laboratory Staff and Health Care Providers (6/24/20)
- NYC Health: COVID-19 Prevention and Groups at Higher Risk (6/11/20)
Effective Data Sources for Re-Linkage to HIV Care Programs (10/20): U.S. federal government efforts to end the HIV epidemic in the United States aim to reduce new infections by 74% by 2025 and 90% by 2030. . . Read more
Current Evidence Suggests Well-Controlled HIV May Not Increase COVID-19 Mortality: As hope that the COVID-19 pandemic would fade after a few months gives way to the reality that spread is likely to persist for some time, knowledge about risks is steadily accumulating . . . Read more
- 12/02/20: CEI at 2020 ETE Clinician Forum: Sexual Health: Focus on Emerging Infections
- 12/02/20: CEI HCV and Drug User Health COE: Urine Drug Testing in Primary Care and Office Based Opioid Treatment
- 12/03/20: CEI at 2020 ETE Clinician Forum: Harm Reduction for Health Care Providers
- 12/07/20: MATEC: Badgers Bounce Back: A Roadmap to Build a SARS-CoV-2 Mitigation Response
- 12/09/20: CEI Sexual Health COE ECHO: Express Visits in Sexual Health Care